arrow_back Back to App

Increased Funding and Reauthorization for Pediatric Cancer and Disease Research.

This Act reauthorizes and significantly increases dedicated federal funding for the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health (NIH). This ensures that substantial public funds will be allocated over the next decade to accelerate research into childhood cancer and other serious pediatric diseases. The goal is to drive medical breakthroughs benefiting children's health.
Key points
Guaranteed continuation and increased funding for pediatric research at the NIH, rising to $25 million annually by fiscal year 2033.
NIH must coordinate pediatric research efforts and prioritize new projects that do not duplicate existing research activities.
Requirement for a report within four years detailing the funded projects and summarizing the advancements made in pediatric research.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_1624
Sponsor: Sen. Kaine, Tim [D-VA]
Process start date: 2023-05-16
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Gabriella Miller Kids First Research Act 2.0

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_1624.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-05-16.

What are the main provisions?

Key points include:

  • Guaranteed continuation and increased funding for pediatric research at the NIH, rising to $25 million annually by fiscal year 2033.
  • NIH must coordinate pediatric research efforts and prioritize new projects that do not duplicate existing research activities.
  • Requirement for a report within four years detailing the funded projects and summarizing the advancements made in pediatric research.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Kaine, Tim [D-VA].

What is the latest detailed status?

The latest detailed status is: Placed on Senate Legislative Calendar under General Orders. Calendar No. 224.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Family